Abstract
A case is presented of a patient with psoriasis in whom squamous cell carcinoma most likely occurred due to the interaction of various factors (psoralen-ultraviolet A therapy, sun exposure, and suppression of natural killer cell function). Therapy consisted of 1 mg/kg/daily of etretinate (Tegison®), which resulted in clearing of psoriatic lesions in one month's time. New carcinomas did not develop and natural killer function improved.
| Original language | English |
|---|---|
| Pages (from-to) | 430-432 |
| Number of pages | 3 |
| Journal | Cutis |
| Volume | 49 |
| Issue number | 6 |
| Publication status | Published - 1992 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Multiple carcinoma in patients with psoriasis caused by psoralen- ultraviolet A therapy, natural killer cell insufficiency, or intensified sun exposure?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver